Adverum Biotechnologies Executives Increase Stake in Company
I'm PortAI, I can summarize articles.
Adverum Biotechnologies executives Laurent Fischer and Peter Soparkar have increased their stakes in the company. Fischer, CEO and President, purchased 128,699 shares for $553,916, raising his ownership to 201,513 shares. Soparkar, COO, acquired 50,000 shares for $211,000, increasing his stake to 80,189 shares. These transactions occurred on December 5 and 8, 2025, at average prices of $4.24 and $4.31 per share.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments